1. Anti-Infective Drug Advisory Committee Meeting. (1998) Guidance documents on developing antimicrobial drugs: general considerations and individual indications. Gaitherburg, MD, July 31, http://0-www.fda.gov.lilac.une.edu/ohrms/dockets/ac/cder98t.htm#Anti-InfectiveDrugs.
2. Bashaw, E.D. (2005) Use of microdialysis in topical drug evaluation: regulatory outlook. In: AAPS Workshop: Microdialysis Principles, Applications and Regulatory Perspective, Nashville, TN, http://www.aapspharmaceutica.com/workshops/Microdialysis110405/bashaw.pdf.
3. Benfeldt, E.M. (2005) Application in bioequivalency. In: AAPS Workshop: Microdialysis Principles, Applications and Regulatory Perspective, Nashville, TN (http://www.aapspharmaceutica.com/workshops/Microdialysis110405/benfeldt.pdf).
4. Effects of P-glycoprotein modulators on etoposide elimination and central nervous system distribution;Burgio;J. Pharmacol. Exp. Ther.,1998
5. Chaurasia, C.S. (2005) Potential role of microdialysis in drug development. In: AAPS Workshop: Microdialysis Principles, Applications and Regulatory Perspective, Nashville, TN, http://www.aapspharmaceutica.com/workshops/Microdialysis110405/chaurasia.pdf.